Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2129 Auburn Ave
Ste 138
Cincinnati, OH 45219Phone+1 513-206-1180
Summary
- Heart Failure, Transplantation, MCS, echocardiography, hemodynamics, research, acute heart failure
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Heart Transplant, LVAD, 1999 - 2000
- University of Massachusetts Medical CenterChief Fellow, Cardiology, 1995 - 1996
- UMass Chan Medical SchoolFellowship, Cardiovascular Disease, 1993 - 1996
- UMass Chan Medical SchoolResidency, Internal Medicine, 1992 - 1993
- Icahn School of Medicine at Mount SinaiResidency, 1990 - 1992
- University of Massachusetts Medical SchoolClass of 1990
- Yale UniversityBS, Biophysics and Biochemistry, 1981 - 1985
Certifications & Licensure
- OH State Medical License 2000 - 2025
- IN State Medical License 2009 - 2023
- MA State Medical License 1992 - 2001
- NY State Medical License 1991 - 2001
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Best Doctors in Cincinnati Cincinnati Magazine, 2004-2023
Publications & Presentations
PubMed
- 116 citationsAtrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.Sanjiv J Shah, Barry A Borlaug, Eugene S Chung, Donald E Cutlip, Philippe Debonnaire
Lancet. 2022-03-19 - 156 citationsBiventricular pacing for atrioventricular block and systolic dysfunction.Anne B Curtis, Seth J Worley, Philip B Adamson, Eugene S Chung, Imran Niazi
The New England Journal of Medicine. 2013-04-25 - 55 citationsLong-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.Deepak L Bhatt, Muthiah Vaduganathan, David E Kandzari, Martin B Leon, Krishna Rocha-Singh
Lancet. 2022-10-22
Professional Memberships
- Fellow
- HFSAFellow
- ISHLTMember
Other Languages
- Korean
Industry Relationships
- Speaker, Boehringer Ingelheim
- Consultant, Doraya
- Consultant, Cardionomic
- Consultant, Intershunt
- Consultant, EBR
- Consultant, Medtronic
- Consultant, Abbott
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: